Displaying One Session

View
Toledo Auditorium (Hall 5) ESMO Colloquium

ESMO Colloquium supported by Daiichi Sankyo Europe GmbH - Relapsed/Refractory FLT3-ITD mutated Acute Myeloid Leukemias (AML) (ID 207)

Date
29.09.2019
Time
18:30 - 20:00
Location
Toledo Auditorium (Hall 5)
Chairs
  • Jorge Cortes (North Augusta, TX, United States of America)
ESMO Colloquium supported by Daiichi Sankyo Europe GmbH - Relapsed/Refractory FLT3-ITD mutated Acute Myeloid Leukemias (AML) ESMO Colloquium

Introduction (ID 6225)

Lecture Time
18:30 - 18:35
Speakers
  • Jorge Cortes (North Augusta, TX, United States of America)
Session Name
ESMO Colloquium supported by Daiichi Sankyo Europe GmbH - Relapsed/Refractory FLT3-ITD mutated Acute Myeloid Leukemias (AML)
Location
Toledo Auditorium (Hall 5), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
18:30 - 20:00
ESMO Colloquium supported by Daiichi Sankyo Europe GmbH - Relapsed/Refractory FLT3-ITD mutated Acute Myeloid Leukemias (AML) ESMO Colloquium

Molecular profiling, prognosis and present Guidelines for Relapsed/Refractory AML (ID 6226)

Lecture Time
18:35 - 18:55
Speakers
  • Lars Bullinger (Berlin, Germany)
Session Name
ESMO Colloquium supported by Daiichi Sankyo Europe GmbH - Relapsed/Refractory FLT3-ITD mutated Acute Myeloid Leukemias (AML)
Location
Toledo Auditorium (Hall 5), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
18:30 - 20:00
ESMO Colloquium supported by Daiichi Sankyo Europe GmbH - Relapsed/Refractory FLT3-ITD mutated Acute Myeloid Leukemias (AML) ESMO Colloquium

Are FLT3 Mutated AML a special entity? (ID 6227)

Lecture Time
18:55 - 19:15
Speakers
  • Gert Ossenkoppele (Amsterdam, Netherlands)
Session Name
ESMO Colloquium supported by Daiichi Sankyo Europe GmbH - Relapsed/Refractory FLT3-ITD mutated Acute Myeloid Leukemias (AML)
Location
Toledo Auditorium (Hall 5), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
18:30 - 20:00
ESMO Colloquium supported by Daiichi Sankyo Europe GmbH - Relapsed/Refractory FLT3-ITD mutated Acute Myeloid Leukemias (AML) ESMO Colloquium

Recent results with FLT3 Inhibitors in FLT3-ITD positive Relapsed/Refractory AML and future development (ID 6228)

Lecture Time
19:15 - 19:45
Speakers
  • Jorge Cortes (North Augusta, TX, United States of America)
Session Name
ESMO Colloquium supported by Daiichi Sankyo Europe GmbH - Relapsed/Refractory FLT3-ITD mutated Acute Myeloid Leukemias (AML)
Location
Toledo Auditorium (Hall 5), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
18:30 - 20:00
ESMO Colloquium supported by Daiichi Sankyo Europe GmbH - Relapsed/Refractory FLT3-ITD mutated Acute Myeloid Leukemias (AML) ESMO Colloquium

Question/Answers from the audience to panelists (ID 6229)

Lecture Time
19:45 - 19:55
Speakers
  • Lars Bullinger (Berlin, Germany)
  • Gert Ossenkoppele (Amsterdam, Netherlands)
Session Name
ESMO Colloquium supported by Daiichi Sankyo Europe GmbH - Relapsed/Refractory FLT3-ITD mutated Acute Myeloid Leukemias (AML)
Location
Toledo Auditorium (Hall 5), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
18:30 - 20:00
ESMO Colloquium supported by Daiichi Sankyo Europe GmbH - Relapsed/Refractory FLT3-ITD mutated Acute Myeloid Leukemias (AML) ESMO Colloquium

Conclusions (ID 6230)

Lecture Time
19:55 - 20:00
Speakers
  • Jorge Cortes (North Augusta, TX, United States of America)
Session Name
ESMO Colloquium supported by Daiichi Sankyo Europe GmbH - Relapsed/Refractory FLT3-ITD mutated Acute Myeloid Leukemias (AML)
Location
Toledo Auditorium (Hall 5), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
18:30 - 20:00